Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project von BRISSE, Hervé J, MCCARVILLE, M. Beth, LEWINGTON, Valerie J, SARNACKI, Sabine, HERO, Barbara, KANEKO, Michio, LONDON, Wendy B, PEARSON, Andrew D. J, COHN, Susan L, MONCLAIR, Tom, GRANATA, Claudio, BARBARA KRUG, K, WOOTTON-GORGES, Sandra L, KANEGAWA, Kimio, GIAMMARILE, Francesco, SCHMIDT, Matthias, SHULKIN, Barry L, MATTHAY, Katherine K

Volltext

Imaging Features of Succinate Dehydrogenase-deficient Pheochromocytoma-Paraganglioma Syndromes von Withey, Samuel Joseph, Perrio, Stephen, Christodoulou, Dimitra, Izatt, Louise, Carroll, Paul, Velusamy, Anand, Obholzer, Rupert, Lewington, Valerie, Jacques, Audrey Eleanor Therese

Volltext

Gender issues in the nuclear medicine community: results from a survey promoted by the EANM Women Empowerment Task Force von Evangelista, Laura, Pietrzak, Agata, Ekmekcioglu, Ozgul, Ovcaricek, Petra Petranovic, Ambrosini, Valentina, Balogova, Sona, Cunha, Lidia, Eccles, Amy, Garibotto, Valentina, Lewington, Valerie, Israel, Ora, Kunikowska, Jolanta

Volltext

In vitro cytotoxicity of Auger electron-emitting [67Ga]Ga-trastuzumab von Othman, Muhamad Faiz bin, Verger, Elise, Costa, Ines, Tanapirakgul, Meena, Cooper, Margaret S., Imberti, Cinzia, Lewington, Valerie J., Blower, Philip J., Terry, Samantha Y.A.

Volltext

The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer von Cook, Gary J. R., Venkitaraman, Ram, Sohaib, Aslam S., Lewington, Valerie J., Chua, Sue C., Huddart, Robert A., Parker, Christopher C., Dearnaley, David D., Horwich, Alan

Volltext

Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy von Illidge, Tim M., Bayne, Mike, Brown, Nicholas S., Chilton, Samantha, Cragg, Mark S., Glennie, Martin J., Du, Yong, Lewington, Valerie, Smart, James, Thom, James, Zivanovic, Maureen, Johnson, Peter W.M.

Volltext

PSMA PET ligands in prostate cancer: a game‐changer? von Dhawan, Ranju T, Barwick, Tara D, Khan, Sameer, Lewington, Valerie J, Dharmarajah, Nishanth

Volltext

Re-assessing gallium-67 as a therapeutic radionuclide von Othman, Muhamad F. bin, Mitry, Nabil R, Lewington, Valerie J, Blower, Philip J, Terry, Samantha Y.A

Volltext

Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management von Kunikowska, Jolanta, Lewington, Valerie, Krolicki, Leszek

Volltext

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of Ra-223-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases von Chittenden, Sarah J., Hindorf, Cecilia, Parker, Christopher C., Lewington, Valerie J., Pratt, Brenda E., Johnson, Bernadette, Flux, Glenn D.

Volltext

Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation von Orchard, Kim, Langford, Jonathan, Guy, Matthew, Lewis, Gemma, Michopoulou, Sofia, Cooper, Margaret, Zvavamwe, Clint, Richardson, Deborah, Lewington, Valerie

Volltext

Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands von Naik, Mitesh, Khan, Sairah R, Lewington, Valerie, Challapalli, Amarnath, Eccles, Amy, Barwick, Tara D

Volltext

Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study von Clement, Dominique, Navalkissoor, Shaunak, Srirajaskanthan, Rajaventhan, Courbon, Frédéric, Dierickx, Lawrence, Eccles, Amy, Lewington, Valerie, Mitjavila, Mercedes, Percovich, Juan Carlos, Lequoy, Benoît, He, Beilei, Folitar, Ilya, Ramage, John

Volltext

Efficacy and safety of 177 Lu-DOTATATE in patients (pts) with advanced pancreatic neuroendocrine tumors (pNETs): Data from the NETTER-R international, retrospective registry von Clement, Dominique, Navalkissoor, Shaunak, Srirajaskanthan, Rajaventhan, Courbon, Frédéric, Dierickx, Lawrence, Eccles, Amy, Lewington, Valerie, Mitjavila, Mercedes, Percovich, Juan Carlos, Lequoy, Benoît, He, Beilei, Folitar, Ilya, Ramage, John

Volltext

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials von Ladenstein, Ruth, Lambert, Bieke, Pötschger, Ulrike, Castellani, Maria-Rita, Lewington, Valerie, Bar-Sever, Zvi, Oudoux, Aurore, Śliwińska, Anna, Taborska, Katerina, Biassoni, Lorenzo, Yanik, Gregory A., Naranjo, Arlene, Parisi, Marguerite T., Shulkin, Barry L., Nadel, Helen, Gelfand, Michael J., Matthay, Katherine K., Park, Julie R., Kreissman, Susan G., Valteau-Couanet, Dominique, Boubaker, Ariane

Volltext

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of ^sup 223^Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metas... von Chittenden, Sarah J, Hindorf, Cecilia, Parker, Christopher C, Lewington, Valerie J, Pratt, Brenda E, Johnson, Bernadette, Flux, Glenn D

Volltext

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases von Chittenden, Sarah J, Hindorf, Cecilia, Parker, Christopher C, Lewington, Valerie J, Pratt, Brenda E, Johnson, Bernadette, Flux, Glenn D

Volltext

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of sigma up 223 nu a-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal... von Chittenden, Sarah J, Hindorf, Cecilia, Parker, Christopher C, Lewington, Valerie J, Pratt, Brenda E, Johnson, Bernadette, Flux, Glenn D

Volltext

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223 Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases von Chittenden, Sarah J., Hindorf, Cecilia, Parker, Christopher C., Lewington, Valerie J., Pratt, Brenda E., Johnson, Bernadette, Flux, Glenn D.

Volltext

Development of 131I-tositumomab von Lewington, Valerie

Volltext